Viewing Study NCT03213002


Ignite Creation Date: 2025-12-25 @ 4:02 AM
Ignite Modification Date: 2026-03-06 @ 5:28 PM
Study NCT ID: NCT03213002
Status: RECRUITING
Last Update Posted: 2025-04-09
First Post: 2017-07-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
Sponsor: Northwell Health
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module